Dr. Barry Dworkin

Measles travel advisories, New Canadian Pharmacare not covering the cost of Ozempic for people with type 2 diabetes, and a possible new treatment pathway for people suffering from Crohn’s disease.

Medical Mythbusting Commentary for February 26, 2024

Source:
Treating newly-diagnosed Crohn’s patients with advanced therapy leads to dramatic improvements in outcomes

Related posts:

  1. Measles now endemic in Europe: The predictable outcome of ignorance, fake data, and anti-science
  2. Measles cases continue to increase in US hitting 25-year high
  3. Follow the bouncing ball: Measles and polio outbreaks playing hopscotch due to low vaccination rates
  4. Reaping the rewards of fake science anti-vaxxers; Measles outbreaks in Europe and Mumps in Canada